Adhesion Barrier Market in terms of revenue was estimated to be worth $0.7 billion in 2023 and is poised to reach $0.9 billion by 2028, growing at a CAGR of 7.4%.
The main drivers of this market’s expansion are the rising number of surgeries and sports-related injuries, an increasing elderly population, and a growing understanding by of the adhesion formation and health issues linked to adhesions. On the other hand, during the forecast period, it is projected that surgeons’ resistance to using adhesion barriers will impede market expansion.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208132543
The adhesion barrier market is a highly fragmented market with the presence of several multinational and local market players. Some of the prominent players include Baxter International (US), Johnson & Johnson (J&J) (US), Becton, Dickinson and Company (US), Betatech Medical (Turkey), CorMatrix Cardiovascular, Inc. (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), Terumo Corporation (Japan), MAST Biosurgery (Switzerland), Innocoll (Ireland), BiosCompass (US), W.L.Gore & Associates (US), and Allosource (US).
Based on products, the adhesion barriers market is further segmented into synthetic and natural adhesion barriers. In 2022, the synthetic adhesion barriers segment accounted for the largest share of the adhesion barriers market. The large number of synthetic adhesion barriers that are commercially available and their higher utilization by surgeons in various surgical procedures as compared to natural adhesion barriers can be attributed to the segment’s growth Also, these are frequently used for open and laparoscopic general surgeries, including those involving the abdomen, pelvis, gynecology, and other surgeries.
Based on the type of formulation, the adhesion barriers market is segmented into film formulations, gel formulations, and liquid formulations. In 2019, gel formulations will grow with highest CAGR during the forecast period in the adhesion barriers market due to the fact that as compared to film-form adhesion barriers, gel-form adhesion barriers carry a lower risk of anastomotic leaks and the associated complications. This is one of the major factors responsible for the growth in demand and preference for gel-form adhesion barriers among end users.
On the basis of region, the adhesion barriers market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. The growing volume of surgical procedures, such as cardiac surgeries, laparoscopic gynecological surgeries, orthopedic surgeries, and general/abdominal surgeries; increasing awareness about the medical implications of adhesions; advanced healthcare system; high public and private healthcare spending; rise in the geriatric population; rising prevalence of chronic and lifestyle diseases and the significant presence of prominent players in the region are the major factors contributing to the growth of North America and the largest share of the adhesion barrier market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=208132543
Adhesion Barrier Market Dynamics:
Drivers:
- Increase in the volume of surgeries and sports-related injuries
Restraints:
- Reluctance of surgeons to use adhesion barriers
Opportunities:
- Untapped emerging markets
Challenges:
- Stringent regulations leading to limited technological innovations
Recent Developments:
- In February 2020, Baxter’s acquired the Seprafilm Adhesion Barrier and related assets from Sanofi to strengthen its hemostate and sealant portfolio and company’s presence in this market.
- In January 2021, Integra Lifesciences Holdings Corporation acquired Acell Inc. This acquisition enables integra to provide more comprehensive complex wound management solutions.
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/adhesion-barrier-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/adhesion-barrier.asp
